Wei Kiong Ngo

912 total citations
27 papers, 576 citations indexed

About

Wei Kiong Ngo is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Wei Kiong Ngo has authored 27 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Ophthalmology, 18 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Wei Kiong Ngo's work include Retinal Diseases and Treatments (19 papers), Retinal Imaging and Analysis (13 papers) and Retinal and Optic Conditions (12 papers). Wei Kiong Ngo is often cited by papers focused on Retinal Diseases and Treatments (19 papers), Retinal Imaging and Analysis (13 papers) and Retinal and Optic Conditions (12 papers). Wei Kiong Ngo collaborates with scholars based in Singapore, United States and Netherlands. Wei Kiong Ngo's co-authors include Colin S. Tan, Tock Han Lim, Kai Xiong Cheong, Nikolle Tan, Louis W. Lim, Jian Ping Chen, Manfred Zierhut, Marc D. de Smet, Bjorn Kaijun Betzler and Su Ling Ho and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Wei Kiong Ngo

23 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Kiong Ngo Singapore 10 529 317 47 41 39 27 576
Danilo Iannetta Italy 14 588 1.1× 403 1.3× 37 0.8× 33 0.8× 93 2.4× 48 674
Salvatore Parrulli Italy 11 414 0.8× 283 0.9× 27 0.6× 21 0.5× 104 2.7× 28 462
Ayman G. Elnahry Egypt 11 280 0.5× 150 0.5× 26 0.6× 52 1.3× 60 1.5× 63 349
Rossella D’Aloisio Italy 15 535 1.0× 413 1.3× 13 0.3× 107 2.6× 40 1.0× 66 649
Hyung Bin Lim South Korea 12 475 0.9× 399 1.3× 13 0.3× 24 0.6× 17 0.4× 33 530
Pradeep Prasad United States 11 432 0.8× 260 0.8× 8 0.2× 51 1.2× 37 0.9× 29 530
Chris Or United States 12 297 0.6× 240 0.8× 12 0.3× 72 1.8× 15 0.4× 22 424
Ki Yup Nam South Korea 12 445 0.8× 320 1.0× 10 0.2× 23 0.6× 62 1.6× 53 484
Kavita V. Bhavsar United States 15 1.0k 2.0× 674 2.1× 16 0.3× 119 2.9× 80 2.1× 23 1.1k
Amir Arabi Iran 9 178 0.3× 116 0.4× 19 0.4× 31 0.8× 75 1.9× 13 310

Countries citing papers authored by Wei Kiong Ngo

Since Specialization
Citations

This map shows the geographic impact of Wei Kiong Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Kiong Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Kiong Ngo more than expected).

Fields of papers citing papers by Wei Kiong Ngo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Kiong Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Kiong Ngo. The network helps show where Wei Kiong Ngo may publish in the future.

Co-authorship network of co-authors of Wei Kiong Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Kiong Ngo. A scholar is included among the top collaborators of Wei Kiong Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Kiong Ngo. Wei Kiong Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Louis W., Wei Kiong Ngo, Yu Qiang Soh, et al.. (2025). Anti-VEGF treatment switch in real-world DME patients: ranibizumab versus aflibercept for bevacizumab DME non-responding patients (SWIRL study). BMJ Open Ophthalmology. 10(1). e002178–e002178.
2.
Ngo, Wei Kiong, et al.. (2023). BULBOSITIES AND INTERVORTEX VENOUS ANASTOMOSIS IN VENOUS OVERLOAD CHOROIDOPATHY MASQUERADING AS POLYPOIDAL CHOROIDAL VASCULOPATHY. Retinal Cases & Brief Reports. 18(4). 436–441. 1 indexed citations
3.
Ngo, Wei Kiong, et al.. (2023). Effects of medications on hypoxia‐inducible factor in the retina: A review. Clinical and Experimental Ophthalmology. 51(3). 205–216. 8 indexed citations
4.
Ngo, Wei Kiong, et al.. (2023). THE WAY PATIENTS SEE FLOATERS. Retina. 43(8). 1240–1245. 4 indexed citations
5.
Ngo, Wei Kiong, Yale L. Fisher, Ronald H. Silverman, Stephen H. Tsang, & Richard F. Spaide. (2023). SCLERAL THICKNESS IN AUTOSOMAL DOMINANT BEST VITELLIFORM MACULAR DYSTROPHY. Retinal Cases & Brief Reports. 18(4). 411–416. 1 indexed citations
6.
Tan, Colin S., et al.. (2022). Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options. SHILAP Revista de lepidopterología. 55 indexed citations
7.
Ngo, Wei Kiong, et al.. (2022). Optical Coherence Tomography Angiography (OCTA) Findings in Retinitis Pigmentosa. Methods in molecular biology. 2560. 101–109.
8.
Ngo, Wei Kiong, et al.. (2022). Correlations of Full-Field Stimulus Threshold With Functional and Anatomical Outcome Measurements in Advanced Retinitis Pigmentosa. American Journal of Ophthalmology. 245. 155–163. 8 indexed citations
9.
Ragi, Sara D., et al.. (2022). Protocol for Indocyanine Green Angiography. Methods in molecular biology. 2560. 161–167. 6 indexed citations
10.
Spaide, Richard F., Yale L. Fisher, Wei Kiong Ngo, & Irene Barbazetto. (2022). REGIONAL SCLERAL THICKNESS AS A RISK FACTOR FOR CENTRAL SEROUS CHORIORETINOPATHY. Retina. 42(7). 1231–1237. 27 indexed citations
11.
Ragi, Sara D., et al.. (2022). Ophthalmic Fluorescein Angiography. Methods in molecular biology. 2560. 153–160. 11 indexed citations
12.
Tan, Colin S., et al.. (2020). Predictors of persistent disease activity following anti-VEGF loading dose for nAMD patients in Singapore: the DIALS study. BMC Ophthalmology. 20(1). 324–324. 7 indexed citations
13.
Ngo, Wei Kiong, et al.. (2020). Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy. BMC Ophthalmology. 20(1). 150–150. 6 indexed citations
14.
Tan, Colin S., Wei Kiong Ngo, Louis W. Lim, Nikolle Tan, & Tock Han Lim. (2019). EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy. Clinical and Experimental Ophthalmology. 47(5). 614–620. 9 indexed citations
15.
Tan, Colin S., et al.. (2016). EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Graefe s Archive for Clinical and Experimental Ophthalmology. 254(10). 1923–1930. 22 indexed citations
16.
Ngo, Wei Kiong & Colin S. Tan. (2015). Effect of bilateral sequential cataract extraction on intraocular pressure in non-glaucomatous Asian eyes. British Journal of Ophthalmology. 100(4). 560–564. 5 indexed citations
17.
Tan, Colin S., Wei Kiong Ngo, Jian Ping Chen, Nikolle Tan, & Tock Han Lim. (2015). EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. British Journal of Ophthalmology. 99(5). 624–628. 100 indexed citations
18.
Tan, Colin S., Wei Kiong Ngo, Louis W. Lim, & Tock Han Lim. (2014). Optical coherence tomography features of Polypoidal Choroidal Vasculopathy and their impact on visual outcomes. Investigative Ophthalmology & Visual Science. 55(13). 4044–4044. 1 indexed citations
19.
Tan, Colin S., Wei Kiong Ngo, & Kai Xiong Cheong. (2014). Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes. British Journal of Ophthalmology. 99(3). 354–358. 68 indexed citations
20.
Ngo, Wei Kiong, et al.. (2010). Correction. British Journal of Ophthalmology. 94(9). 1268.2–1268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026